Pure Ratios Releases New CBD Capsule Line
Ryan Allway
August 21st, 2019
News
Pure Ratios Holdings, a subsidiary of 4Front Ventures Corp (CSE:FFNT.CN)(OTCQX:FFNTF), unveils the release of Pure Ratios Essentials: a new line of CBD capsules formulated with adaptogenic* herbs and mushrooms in four innovative directions.
SAN DIEGO, CA / ACCESSWIRE / August 21, 2019 / Pure Ratios proudly announces the release of their new adaptogenic* CBD capsule line in four distinct formulations: Move, Calm, Think, and Boost. The Pure Ratios Essentials line is the latest offering from the holistic wellness brand, taking an herbalist’s approach to CBD Hemp. Each capsule is formulated with classical Chinese herbs, mushrooms, and 15 mg of water-soluble CBD Hemp to support balance and restoration, while promoting health and vitality.
Pure Ratios Essentials are uniquely designed to integrate both modern scientific and classical methods empirically derived over the past 5,000 years. Each formula contains adaptogenic* herbs, which help the body adapt to stressors-emotional, physical, or otherwise, and facilitate balance. The line uses high-quality water-soluble CBD hemp, significantly boosting bioavailability and maximizing CBD benefits. All of the adaptogenic* herbs in the formulas are water-soluble as well, ensuring that everything is absorbed at the same time to bring balance to the system in an extremely efficient way.
IN THE SPIRIT OF SHENNONG
Pure Ratios Essentials were made in the spirit Shennong, the legendary ruler of prehistoric China. This Emperor, also known as the Divine Farmer, named a special class of herbs “superior herbs,” known today as “adaptogens.” The Divine Farmer found that when consumed individually, adaptogens may not have much effect, but with proper formulation, incredible results happen. Shennong’s gifts to humanity laid the basis for Pure Ratios’ unique and synergistic approach to CBD hemp today.
MOVE FORMULA
Pure Ratios Move Formula combines adaptogenic* Chinese herbs to relieve bodily stress and discomfort while supporting the musculoskeletal system. Each serving contains 15 mg of water-soluble CBD hemp complemented with turmeric, red peony, schisandra, and ginger for maximal mobility and overall well-being. Available in stores and online at www.pureratioscbd.com on August 20th, 2019. // MSRP $69.00 USD
CALM FORMULA
Pure Ratios Calm Formula focuses on Chinese herbs and a functional mushroom that relieve stress and frustration while promoting relaxation. Each serving contains 15 mg of water-soluble CBD hemp combined with albizzia, polygala root, schisandra, salvia root, and reishi mushrooms that encourage ease and overall well-being. Available in stores and online at www.pureratioscbd.com on August 20th, 2019 // MSRP $69.00 USD
THINK FORMULA
Pure Ratios Think Formula complements Chinese herbs, Ayurvedic herbs, and functional mushrooms that elevate normal cognitive and neurological function while stimulating memory. Each CBD capsule contains 15 mg of water-soluble CBD Hemp synthesized with white peony, salvia root, bacopa, schisandra, and lion’s mane mushrooms for increased focus and vitality. Available in stores and online at www.pureratioscbd.com on August 20th, 2019 // MSRP $69.00 USD
BOOST FORMULA
Pure Ratios Boost Formula uses five Chinese herbs to increase energy and support the immune system, all the while promoting rejuvenation. Each capsule contains 15 mg of water-soluble CBD Hemp combined with two power herbs, schisandra and eleuthero, and three functional mushrooms: reishi, cordyceps, and chaga to boost the overall bodily system and maximize well-being. Available in stores and online at www.pureratioscbd.com on August 20th, 2019// MSRP $69.00 USD
A NEW ERA
The Pure Essentials launch is the first product line to hit the market under the tutelage of Pure Ratios’ new parent company, 4Front Ventures Corp, who are celebrating their recent merger between Cannex and 4Front. The merger combines Cannex’s precision cultivation and manufacturing with 4Front’s long-standing retail, regulatory, and growth capabilities. The new company began trading on the Canadian Securities Exchange (CSE) on August 6, 2019, under the ticker FFNTF.CN.
Josh Rosen, CEO of 4Front Ventures notes, “We all bring different strengths to this combination and… we prioritize being authentic, open-minded, forward-looking and driven.” Chad Conner, Pure Ratios CEO adds, “I couldn’t be happier about our combined future after the first couple of months integrating with Cannex and seeing the 4Front team in action–this combination of great people, strong capabilities, and an amazing market opportunity has the Pure Ratios team committed to doing our part in building something awesome.”
For more information please visit www.PureRatios.com and www.pureratioscbd.com.
About Pure Ratios
Founded in 2015, Pure Ratios is a San Diego based health and wellness brand that takes an herbalist’s approach to healing with cannabis. They spearhead the wellness division of 4Front Ventures, with their proprietary formulations developed by seasoned Eastern medicine practitioners, Chad and Hind Conner. Known for the only 96-hour CBD pain patch on the market, Pure Ratios’ innovative products are each formulated with a carefully chosen combination of plants that enhance the adaptogenic powers of cannabis. This synergistic approach, unique in the market, is backed by the latest cannabis science and years of clinical research. Every one of their wellness products is also rooted in superior sourcing and continue to be refined in their own holistic healing clinics every day.
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Abi Cotler
Abi@pureratios.com
619-955-1339
SOURCE: 4Front Ventures Corp
Related Documents
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
PotBotics is a leading data aggregation and technology company focused on the global medical cannabis market.
cbdMD Inc. (NYSE: YCBD) is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD vape oils, and CBD pet products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
